{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T20:51:35Z","timestamp":1770324695462,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jgar.2019.02.016","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T12:37:58Z","timestamp":1551271078000},"page":"28-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Infections by OXA-48-like-producing Klebsiella pneumoniae non-co-producing extended-spectrum beta-lactamase: Can they be successfully treated with cephalosporins?"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5608-3090","authenticated-orcid":false,"given":"Laura","family":"Escol\u00e0-Verg\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nieves","family":"Larrosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibai","family":"Los-Arcos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belen","family":"Vi\u00f1ado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jos\u00e9","family":"Gonz\u00e1lez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carles","family":"Pigrau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benito","family":"Almirante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Len","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2019.02.016_bib0005","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00079-17","article-title":"Treatment of infections caused by extended-spectrum-beta-lactamase-, AmpC-, and carbapenemase-producing Enterobacteriaceae","volume":"31","author":"Rodr\u00edguez-Ba\u00f1o","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2019.02.016_bib0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/AAC.48.1.15-22.2004","article-title":"Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae","volume":"48","author":"Poirel","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.02.016_bib0015","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1128\/AAC.01452-10","article-title":"Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France","volume":"55","author":"Cuzon","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.02.016_bib0020","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ijantimicag.2008.01.017","article-title":"Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss","volume":"31","author":"G\u00fclmez","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2019.02.016_bib0025","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1128\/AAC.00543-08","article-title":"Plasmid-encoded carbapenem-hydrolyzing-lactamase OXA-48 in an imipenem-susceptible Klebsiella pneumoniae strain from Belgium","volume":"52","author":"Cuzon","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.02.016_bib0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jhin.2017.02.024","article-title":"Dissemination and clinical implications of multidrug-resistant Klebsiella pneumoniae isolates producing OXA-48 in a Spanish hospital","volume":"96","author":"Madue\u00f1o","year":"2017","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jgar.2019.02.016_bib0035","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/jac\/dks121","article-title":"OXA-48-like carbapenemases: the phantom menace","volume":"67","author":"Poirel","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2019.02.016_bib0040","doi-asserted-by":"crossref","first-page":"E72","DOI":"10.1111\/1469-0691.12091","article-title":"Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge","volume":"19","author":"Navarro-San Francisco","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2019.02.016_bib0045","doi-asserted-by":"crossref","first-page":"20723","DOI":"10.2807\/1560-7917.ES2014.19.9.20723","article-title":"Successful control of a hospital-wide outbreak of OXA-48 producing Enterobacteriaceae in the Netherlands, 2009 to 2011","volume":"19","author":"Dautzenberg","year":"2014","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.jgar.2019.02.016_bib0050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/jac\/dks364","article-title":"Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak","volume":"68","author":"Pano-Pardo","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2019.02.016_bib0055","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1128\/AAC.06069-11","article-title":"Broad-spectrum \u03b2-lactam antibiotics for treating experimental peritonitis in mice due to Klebsiella pneumoniae producing the carbapenemase OXA-48","volume":"56","author":"Mimoz","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.02.016_bib0060","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1128\/AAC.01947-13","article-title":"Efficacy of humanized carbapenem and ceftazidime regimens against Enterobacteriaceae producing OXA-48 carbapenemase in a murine infection model","volume":"58","author":"Wiskirchen","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.02.016_bib0065","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/jac\/dkq504","article-title":"Transfer of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae from Turkey to France","volume":"66","author":"Levast","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2019.02.016_bib0070","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/jac\/dkq467","article-title":"Plasmid-encoded OXA-48 carbapenemase in Escherichia coli from Israel","volume":"66","author":"Goren","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2019.02.016_bib0075","series-title":"Breakpoint tables for interpretation of MICs and zone diameters. Version 8.1 May","author":"European Committee on Antimicrobial Susceptibility Testing (EUCAST)","year":"2018"},{"key":"10.1016\/j.jgar.2019.02.016_bib0080","series-title":"EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and\/or epidemiological importance. Version 2.0 July","year":"2017"},{"key":"10.1016\/j.jgar.2019.02.016_bib0085","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/1469-0691.12678","article-title":"Detection of carbapenemases in Enterobacteriaceae: a challenge for diagnostic microbiological laboratories","volume":"20","author":"Hrab\u00e1k","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2019.02.016_bib0090","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/cid\/cir887","article-title":"Efficacy of imipenem for the treatment of bacteremia due to an OXA-48-producing Klebsiella pneumoniae isolate","volume":"54","author":"Maherault","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2019.02.016_bib0095","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1128\/AAC.01672-07","article-title":"Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey","volume":"52","author":"Carrer","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.02.016_bib0100","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01195-18","article-title":"Treatment of infections with OXA-48 producing Enterobacteriaceae","author":"Stewart","year":"2018","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716519300566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716519300566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:53:32Z","timestamp":1761990812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716519300566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":20,"alternative-id":["S2213716519300566"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2019.02.016","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infections by OXA-48-like-producing Klebsiella pneumoniae non-co-producing extended-spectrum beta-lactamase: Can they be successfully treated with cephalosporins?","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2019.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}